Edition:
India

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
19 Jan 2018
Change (% chg)

$-0.01 (-1.58%)
Prev Close
$0.60
Open
$0.60
Day's High
$0.62
Day's Low
$0.55
Volume
286,101
Avg. Vol
165,857
52-wk High
$5.02
52-wk Low
$0.50

Select another date:

Wed, Nov 15 2017

BRIEF-Immune Pharmaceuticals reports Q3 results

* Immune Pharmaceuticals announces third quarter 2017 financial results and provides a corporate update

BRIEF-Immune Pharmac prices $18 mln public offering

* Immune Pharmaceuticals Inc announces pricing of $18,000,000 public offering of convertible preferred stock and warrants

BRIEF-Immune Pharmaceuticals announces positive results from ongoing phase 2 trial of bertilimumab

* Immune Pharmaceuticals announces positive results from ongoing phase 2 trial of bertilimumab in bullous pemphigoid

BRIEF-Immune Pharmaceuticals appoints Daniel Teper as CEO for Cytovia

* Immune Pharmaceuticals provides research and development and business update and summary of recent financial highlights.

BRIEF-Immune Pharmaceuticals files for non-timely 10-Q

* Immune Pharmaceuticals Inc files for non-timely 10-Q - sec filing Source text: (http://bit.ly/2fFbJWp) Further company coverage:

Select another date: